Abstract:
Compounds containing stereogenic phosphorus atoms played a historically important role in the development of asymmetric catalysis, exemplified by early P-chiral phosphine ligands such as DIPAMP. More recently, P-stereogenic motifs have emerged in medicinal chemistry, as a growing number of drugs contain stereogenic P(V) centers bearing predominantly phosphorus–heteroatom bonds, which present distinct synthetic challenges.